Is it possible to achieve a safe glycated hemoglobin level during intensive hypoglycemic therapy? (results of ADVANCE study)

Aim. To study efficacy of glycemic control in terms of reduced HbA1c level using glyclazide modified release (MR) in patients with DM2 and differentclinical characteristics at the initial stage of therapy in the framework of ADVANCE study (Action in Diabetes and Vascular Disease: Preterax andDiamic...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina Vladimirovna Shestakova, Minara Shamkhalovna Shamkhalova
Format: Article
Language:English
Published: Endocrinology Research Centre 2011-06-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5646
Tags: Add Tag
No Tags, Be the first to tag this record!